Transgender individuals who undergo gender-affirming medical or surgical therapies are at
risk for infertility. Suppression of puberty with gonadotropin-releasing hormone agonist …

BACKGROUND Many transgender individuals choose to undergo gender-affirming
hormone treatment (GAHT) and/or sex reassignment surgery (SRS) to alleviate the distress …

Background: Transgender healthcare is a rapidly evolving interdisciplinary field. In the last
decade, there has been an unprecedented increase in the number and visibility of …

Background Hormonal treatments and surgical interventions practiced with the aim to affirm
gender identity in transgender and gender diverse patients may impact their future …

STUDY QUESTION Can transgender women cryopreserve germ cells obtained from their
orchiectomy specimen for fertility preservation, after having used puberty suppression and/or …

The gender diverse and transgender community is a minor patient group that is encountered
with increasing frequency in the clinical setting, attributed to the improved awareness and …

Gender affirmation surgery is paramount in the treatment of gender dysphoria for
transgender individuals. For transgender women, vaginoplasty offers the opportunity for …

There is currently a paucity of data on the fertility effects of gender-affirming hormones,
necessitating fertility preservation counseling prior to initiation of therapy. Several …

Abstract Since 2007, the Oncofertility Consortium Annual Conference has brought together a
diverse network of individuals from a wide range of backgrounds and professional levels to …

Objective To assess the incidence of testicular cancer in trans women (male sex assigned at
birth, female gender identity) using gender‐affirming hormonal treatment. Patients and …